NVTA实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (15 Feb 2024 @ 04:59):

Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally...

Stats
今日成交量	22.46M
平均成交量	12.70M
市值	5.44M
EPS	$0 ( 2024-02-27 )
下一个收益日期	( $0 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.00354
ATR14	$0.0380 (237.50%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-20	Nussbaum Robert L	Sell	17 404	Common Stock
2023-12-20	Brida Thomas	Sell	17 404	Common Stock
2023-11-13	Sholehvar David	Buy	850 000	Common Stock
2023-11-13	Sholehvar David	Buy	0
2023-10-18	Brida Thomas	Buy	229 500	Common Stock

INSIDER POWER
90.41
Last 92 transactions
Buy: 9 089 738 \| Sell: 529 241

音量相关性

長: -0.23 (neutral)

短: -0.96 (very strong negative)

Signal:(21.881) Possible Trading Opportunity Present (swing)

Invitae Corp 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Invitae Corp 相关性 - 货币/商品

-0.76
( moderate negative )

-0.78
( moderate negative )

0.81
( strong )

-0.78
( moderate negative )

0.77
( moderate )

Invitae Corp 财务报表

Annual	2022
营收:	$516.30M
毛利润:	$99.05M (19.18 %)
EPS:	$-13.18

FY	2022
营收:	$516.30M
毛利润:	$99.05M (19.18 %)
EPS:	$-13.18

FY	2021
营收:	$460.45M
毛利润:	$111.78M (24.28 %)
EPS:	$-1.736

FY	2020
营收:	$279.60M
毛利润:	$81.32M (29.09 %)
EPS:	$-4.52

Financial Reports:

No articles found.

Invitae Corp

Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.